These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 17980954

  • 1. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Feil G, Maurer S, Nagele U, Krug J, Bock C, Sievert KD, Stenzl A.
    Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954
    [Abstract] [Full Text] [Related]

  • 2. Editorial comment on: immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Papatsoris A, Deliveliotis C.
    Eur Urol; 2008 May; 53(5):1073. PubMed ID: 17980953
    [No Abstract] [Full Text] [Related]

  • 3. In vitro investigations of tissue-engineered multilayered urothelium established from bladder washings.
    Nagele U, Maurer S, Feil G, Bock C, Krug J, Sievert KD, Stenzl A.
    Eur Urol; 2008 Dec; 54(6):1414-22. PubMed ID: 18280635
    [Abstract] [Full Text] [Related]

  • 4. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.
    Koga F, Kawakami S, Fujii Y, Saito K, Ohtsuka Y, Iwai A, Ando N, Takizawa T, Kageyama Y, Kihara K.
    Clin Cancer Res; 2003 Nov 15; 9(15):5501-7. PubMed ID: 14654529
    [Abstract] [Full Text] [Related]

  • 5. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
    Esheba GE, Longacre TA, Atkins KA, Higgins JP.
    Am J Surg Pathol; 2009 Mar 15; 33(3):347-53. PubMed ID: 19092634
    [Abstract] [Full Text] [Related]

  • 6. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, Marinelli RJ, Presti JC, van de Rijn M, Brooks JD.
    Am J Surg Pathol; 2007 May 15; 31(5):673-80. PubMed ID: 17460449
    [Abstract] [Full Text] [Related]

  • 7. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R, Tsybrovskyy O, Ratschek M, Rehak P, Lipsky K, Langner C.
    Urology; 2004 Jun 15; 63(6):1079-83. PubMed ID: 15183954
    [Abstract] [Full Text] [Related]

  • 8. Generation of a functional, differentiated porcine urothelial tissue in vitro.
    Turner AM, Subramaniam R, Thomas DF, Southgate J.
    Eur Urol; 2008 Dec 15; 54(6):1423-32. PubMed ID: 18395964
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia.
    Mallofré C, Castillo M, Morente V, Solé M.
    Mod Pathol; 2003 Mar 15; 16(3):187-91. PubMed ID: 12640096
    [Abstract] [Full Text] [Related]

  • 10. Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?
    Riedel I, Liang FX, Deng FM, Tu L, Kreibich G, Wu XR, Sun TT, Hergt M, Moll R.
    Eur J Cell Biol; 2005 Mar 15; 84(2-3):393-405. PubMed ID: 15819416
    [Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M, Omran Z, Nosseir M, Lotfy A, Swellam T.
    APMIS; 2009 Jan 15; 117(1):45-52. PubMed ID: 19161536
    [Abstract] [Full Text] [Related]

  • 12. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
    Cox RM, Schneider AG, Sangoi AR, Clingan WJ, Gokden N, McKenney JK.
    Am J Surg Pathol; 2009 Aug 15; 33(8):1213-9. PubMed ID: 19542871
    [Abstract] [Full Text] [Related]

  • 13. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S, Lucciarini R, Amantini C, Nabissi M, Canesin G, Ballarini P, Di Spilimbergo A, Cardarelli MA, Servi L, Mammana G, Santoni G.
    Eur Urol; 2008 Sep 15; 54(3):612-20. PubMed ID: 17977643
    [Abstract] [Full Text] [Related]

  • 14. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF, Epstein JI.
    Am J Surg Pathol; 2007 Mar 15; 31(3):390-7. PubMed ID: 17325480
    [Abstract] [Full Text] [Related]

  • 15. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia.
    Desai S, Lim SD, Jimenez RE, Chun T, Keane TE, McKenney JK, Zavala-Pompa A, Cohen C, Young RH, Amin MB.
    Mod Pathol; 2000 Dec 15; 13(12):1315-23. PubMed ID: 11144928
    [Abstract] [Full Text] [Related]

  • 16. Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur.
    Barbisan F, Santinelli A, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M, van der Kwast T, Montironi R.
    Cancer; 2008 Feb 01; 112(3):636-44. PubMed ID: 18072261
    [Abstract] [Full Text] [Related]

  • 17. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
    Moll R, Achtstätter T, Becht E, Balcarova-Ständer J, Ittensohn M, Franke WW.
    Am J Pathol; 1988 Jul 01; 132(1):123-44. PubMed ID: 2456018
    [Abstract] [Full Text] [Related]

  • 18. Differentiation-dependent localisation of tissue-type plasminogen activator in human bladder urothelium.
    Makuc J, Masera A, Trsinar B, Jezernik K.
    Cell Biol Int; 2004 Jul 01; 28(5):381-6. PubMed ID: 15193281
    [Abstract] [Full Text] [Related]

  • 19. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.
    Ohtsuka Y, Kawakami S, Fujii Y, Koga F, Saito K, Ando N, Takizawa T, Kageyama Y, Kihara K.
    BJU Int; 2006 Jun 01; 97(6):1322-6. PubMed ID: 16686732
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra.
    Chaux A, Han JS, Lee S, Gonzalez-Roibon N, Sharma R, Burnett AL, Cubilla AL, Netto GJ.
    Hum Pathol; 2013 Dec 01; 44(12):2760-7. PubMed ID: 24134931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.